Author: Lumangtad, Liezel A.; Bell, Thomas W.
Title: The signal peptide as a new target for drug design Cord-id: oh85yi49 Document date: 2020_5_15
ID: oh85yi49
Snippet: Many current and potential drug targets are membrane-bound or secreted proteins that are expressed and transported via the Sec61 secretory pathway. They are targeted to translocon channels across the membrane of the endoplasmic reticulum (ER) by signal peptides (SPs), which are temporary structures on the N-termini of their nascent chains. During translation, such proteins enter the lumen and membrane of the ER by a process known as co-translational translocation. Small molecules have been found
Document: Many current and potential drug targets are membrane-bound or secreted proteins that are expressed and transported via the Sec61 secretory pathway. They are targeted to translocon channels across the membrane of the endoplasmic reticulum (ER) by signal peptides (SPs), which are temporary structures on the N-termini of their nascent chains. During translation, such proteins enter the lumen and membrane of the ER by a process known as co-translational translocation. Small molecules have been found that interfere with this process, decreasing protein expression by recognizing the unique structures of the SPs of particular proteins. The SP may thus become a validated target for designing drugs for numerous disorders, including certain hereditary diseases.
Search related documents:
Co phrase search for related documents- action mechanism and low efficacy: 1, 2, 3, 4
- action mechanism and low potency: 1, 2
- active site and low cytotoxicity: 1, 2
- active site and low potency: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date